Issei Okunaga

Issei Okunaga

Auto-generated profile, based on publicly available information

Issei Okunaga

Department of Nephrology, Graduate School of Medicine, Chiba University, Chiba, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2023 in PNAS Nexus
Verified
Journal Article
Open access
PDF file
HYHiroyuki Yamada
Hiroyuki Yamada
SMShin-Ichi Makino
Shin-Ichi Makino
IOIssei Okunaga
Issei Okunaga
TMTakafumi Miyake
Takafumi Miyake
KYKanae Yamamoto-Nonaka
Kanae Yamamoto-Nonaka
KAKatsuhiko Asanuma
Katsuhiko Asanuma
The spatial organization of various cell populations is critical for the major physiological and pathological processes in the kidneys. Most evaluation of these processes typically comes from a conventional 2D tissue cross-section, visualizing a limited amount of cell organization. Therefore, the 2D analysis of kidney biopsy introduces selection bias. The 2D analysis potentially omits key pathological findings outside a 1- to 10-μm thin-sectioned area and lacks information on tissue organization, especially in a particular irregular structure such as crescentic glomeruli. In this study, we introduce an easy-to-use and scalable method for obtaining high-quality images of molecules of interest in a large tissue volume, enabling a comprehensive evaluation of the 3D organization and cellular composition of kidney tissue, especially the glomerular structure. We show that CUBIC and ScaleS clearing protocols could allow a 3D analysis of the kidney tissues in human and animal models of kidney disease. We also demonstrate that the paraffin-embedded human biopsy specimens previously examined via 2D evaluation could be applicable to 3D analysis, showing a potential utilization of this method in kidney biopsy tissue collected in the past. In summary, the 3D analysis of kidney biopsy provides a more comprehensive analysis and a minimized selection bias than 2D tissue analysis. Additionally, this method enables a quantitative evaluation of particular kidney structures and their surrounding tissues, with the potential utilization from basic science investigation to applied diagnostics in nephrology.

15 March 2023 in CEN Case Reports
Verified
Journal Article
Closed access
PDF file
IOIssei Okunaga
Issei Okunaga
SMShin-Ichi Makino
Shin-Ichi Makino
DHDaisuke Honda
Daisuke Honda
NTNarihito Tatsumoto
Narihito Tatsumoto
MAMasashi Aizawa
Masashi Aizawa
KAKatsuhiko Asanuma
Katsuhiko Asanuma

3 November 2025 in Kidney360
Verified
Journal Article
Open access
MIMariko Ida
Mariko Ida
HYHiroyuki Yamada
Hiroyuki Yamada
NSNaritoshi Shirata
Naritoshi Shirata
SMShin-Ichi Makino
Shin-Ichi Makino
KIKoichiro Ichimura
Koichiro Ichimura
KAKatsuhiko Asanuma
Katsuhiko Asanuma
Key Points: The loss of membrane-associated guanylate kinase inverted 2 (MAGI-2) induces actin cytoskeleton reorganization in mice. MAGI-2, α -actinin-4, and synaptopodin form a complex in vitro . Regulating MAGI-2 has the potential to suppress foot process effacement and is a promising target for podocyte damage. Background: Podocytes form interdigitating foot processes connected by the slit diaphragm (SD), which serves as a size-selective and charge-selective barrier essential for glomerular filtration. In kidney diseases, it is known that podocyte injury leads to the reorganization of the actin cytoskeleton, resulting in foot process effacement, which contributes to proteinuria and the progression of the disease. However, the detailed mechanisms underlying the regulation of actin cytoskeleton reorganization remain unclear. This study aims to elucidate the role of the scaffolding protein membrane-associated guanylate kinase inverted 2 (MAGI-2) in actin cytoskeleton regulation and to explore its potential as a novel therapeutic target. Methods: MAGI-2 was specifically knocked out in podocytes, and the localization changes of the actin cytoskeleton were observed in mice. In addition, immunoprecipitation experiments were performed in cultured cells to identify the binding domains of MAGI-2 with α -actinin-4 and synaptopodin (Synpo), key components of the actin cytoskeleton, and their colocalization changes were analyzed. Results: In the absence of MAGI-2 in podocytes, actin bundles normally located in the center of the foot processes were found to shift toward the basement membrane, indicating that MAGI-2 contributes to cytoskeletal reorganization. Immunoprecipitation revealed that MAGI-2 forms a complex with Synpo and α -actinin-4, and co-expression in cultured podocytes induced a relocalization of the actin cytoskeleton toward cell-cell contact. These findings suggest that MAGI-2, in addition to its previously known role as a scaffolding protein of the SD, directly interacts with actin-associated proteins and plays a critical role in the reorganization of the podocyte cytoskeleton. Conclusions: MAGI-2 binds to Synpo and α -actinin-4, regulating actin filament localization and contributing to cytoskeletal reorganization in podocytes. These findings uncover a new molecular link between SD components and the actin cytoskeleton, offering insights into mechanisms of podocyte injury.

23 September 2025 in JCI Insight
Verified
Journal Article
Open access
PDF file
IKIka N. Kadariswantiningsih
Ika N. Kadariswantiningsih
IOIssei Okunaga
Issei Okunaga
KYKaho Yamasaki
Kaho Yamasaki
MEMaulana Empitu
Maulana Empitu
HYHiroyuki Yamada
Hiroyuki Yamada
KAKatsuhiko Asanuma
Katsuhiko Asanuma
Glomerular inflammation and podocyte loss are the hallmarks of chronic kidney disease (CKD) progression. Understanding how podocytes and their microenvironment regulate inflammation is critical for developing effective therapies. In this study, we identified C-C chemokine ligand 5 (CCL5) as an inflammatory mediator elevated in injured podocytes, based on analyses of both human kidney biopsies and mouse models of CKD. We discovered that CCL5 exerts paradoxical effects in nephropathy; while it protects podocytes in vitro, it exacerbates glomerular injury in vivo. Recombinant CCL5 and podocyte-specific CCL5 overexpression promoted cell survival and reduced apoptosis in cultured podocytes. However, in adriamycin-induced nephropathy, CCL5 worsened glomerular injury, increasing proteinuria, glomerulosclerosis, and podocyte loss. Bone marrow (BM) transplantation experiments revealed that CCL5 in BM-derived cells — not kidney-resident cells — drove disease progression. CCL5 deficiency in BM-derived cells conferred protection by increasing reparative M2 macrophages, whereas endogenous CCL5 promoted M1 polarization, inhibited M2 differentiation, and triggered M2-to-M1 transition. These findings demonstrate that while CCL5 supports podocyte survival, its expression in BM-derived cells promotes inflammatory macrophage phenotypes and glomerular injury. The harmful immune effects of CCL5 in BM-derived cells outweigh its podocyte-protective role, highlighting the importance of cell-targeted strategies to mitigate kidney damage.